"Personalised medicine - the ability to choose drugs best suited to each patient -
is a much talked about goal in the pharmaceutical industry.
Imperial Professor Jeremy Nicholson believes it can never be achieved
if we continue to ignore the effects of the bacteria in our guts on the drugs we take.
We found a stack of evidence that gut micro-organisms change drug metabolism fundamentally," says Nicholson.
Each one of us has up to 2kg of symbiotic bacteria in our gut.
"Most of our drugs don't work in most patients," Allen Roses, a senior executive from GlaxoSmithKline,
announces unashamedly at a London conference", 19.06.05,